Parkinson's Trial NCT06908460
Reduce complications through staff training
- Trial ID
- NCT06908460
- Official Title
- The Link Between the Training of Nursing Home Professionals and the Quality of Life of Residents With Parkinson's Disease
- Goal
- Reduce complications through staff training
- Status
- RECRUITING
- Sponsor
- University Hospital, Grenoble
- Study Type
- OBSERVATIONAL
- Enrollment
- 90 participants
- Conditions
- Parkinson Disease
Summary For Families
Researchers want to know whether training nursing home professionals can improve the daily quality of life for people living with Parkinson's disease. They will compare staff training levels and content with residents' outcomes by using questionnaires and interviews that track symptoms, daily functioning, mood, and medication management. The training is meant to help staff better recognize motor and nonmotor symptoms, time and manage levodopa and other medications safely, support mobility and daily tasks, and communicate care needs to families, which could reduce complications and boost comfort. The study plans to enroll about 90 adults aged 18 and up with a confirmed Parkinson's diagnosis who live in EHPADs in departments 38, 73, 74, 26, or 07 in the AURA region and who can cooperate with the questionnaires; residents who object or who are under certain legal protections are excluded.
Locations
- CHU Grenoble Alpes, Grenoble, France
Frequently Asked Questions
- What is this trial testing?
- This trial is studying an experimental treatment. Researchers want to know whether training nursing home professionals can improve the daily quality of life for people living with Parkinson's disease. They will compare staff training levels and content with residents' outcomes by using questionnaires and interviews that track symptoms, daily functioning, mood, and medication management. The training is meant to help staff better recognize motor and nonmotor symptoms, time and manage levodopa and other medications safely, support mobility and daily tasks, and communicate care needs to families, which could reduce complications and boost comfort. The study plans to enroll about 90 adults aged 18 and up with a confirmed Parkinson's diagnosis who live in EHPADs in departments 38, 73, 74, 26, or 07 in the AURA region and who can cooperate with the questionnaires; residents who object or who are under certain legal protections are excluded.
- Who can participate?
- Participants must be at least 18 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 2 years and 3 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This is an observational study, so there is no placebo and no experimental treatment is assigned. Researchers observe and collect information while you continue your usual care.